Are acceptance and mindfulness‐based interventions ‘value for money’? Evidence from a systematic literature review
Open accessAbstract
Objectives: Acceptance and mindfulness‐based interventions (A/ MBI s) are recommended for people with mental health conditions. Although there is a growing evidence base supporting the effectiveness of different A/ MBI s for mental health conditions, the economic case for these interventions has not been fully explored. The aim of this systematic review was to identify and appraise all available economic evidence of A/ MBI s for the management of mental health conditions. Methods: Eight electronic bibliographic databases ( MEDLINE , MEDLINE In‐Process & Other Non‐Indexed Citations, EMBASE , Web of Science, NHS Economic Evaluation Database ( EED ), Database of Abstracts of Reviews of Effects ( DARE ), Health Technology Assessment ( HTA ) database, and EconLit) were searched for relevant economic evaluations published from each database's inception date until November 2017. Study selection, quality assessment, and data extraction were carried out according to published guidelines. Results: Ten relevant economic evaluations presented in 11 papers were identified. Seven of the included studies were full economic evaluations (i.e., costs and effects assessed), and three studies were partial economic evaluations (i.e., only costs were considered in the analysis). The A/ MBI s that had been subjected to economic evaluation were acceptance and commitment therapy ( ACT ), dialectical behaviour therapy ( DBT ), mindfulness‐based cognitive therapy ( MBCT ), and mindfulness‐based stress reduction ( MBSR ). In terms of clinical presentations, the evaluation of cost‐effectiveness of A/ MBI s has been more focused on depression and emotional unstable personality disorder with three and four economic evaluations, respectively. Three out of seven full economic evaluations observed that A/ MBI s were cost‐effective for the management of mental health conditions. Nevertheless, the heterogeneity of included populations, interventions, and economic evaluation study types limits the extent to which firm conclusions can currently be made. Conclusion: This first substantive review of economic evaluations of A/ MBI s indicates that more research is needed before firm conclusions can be reached on the cost‐effectiveness of A/ MBI s for mental health conditions. Practitioner points: The findings of the review provide information that may be relevant to mental health service commissioners and decision‐makers as all economic evidence available on acceptance and mindfulness‐based interventions for mental health conditions is summarized. Evidence relating to the cost‐effectiveness and cost‐saving potential of acceptance and mindfulness‐based interventions is focused mainly on depression and emotional unstable personality disorder to date. Heterogeneity in the specific forms of acceptance and mindfulness‐based interventions may limit generalizability of the findings. The number of health economic evaluations relating to acceptance and mindfulness‐based interventions remains relatively small. Further research in this area is required.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review identified 10 economic evaluations (in 11 papers) of acceptance and mindfulness-based interventions (A/MBIs) for mental health conditions. It found that only 3 of 7 full economic evaluations suggested A/MBIs were cost-effective, while the 3 partial evaluations reported cost-savings, and heterogeneity limited firm conclusions.
Key findings
- Ten relevant economic evaluations were included: 7 full economic evaluations and 3 partial economic evaluations. The A/MBIs evaluated were ACT, DBT, MBCT, and MBSR, with depression (3 evaluations) and emotionally unstable personality disorder (EUPD; 4 evaluations) the most studied conditions.
- Three of seven full economic evaluations observed A/MBIs to be cost-effective; one found MBCT not cost-effective (dominated by maintenance antidepressant treatment), and the remaining full evaluations were inconclusive. The three partial economic evaluations reported cost-savings.
- Reported economic results included DBT mean saving of £1,741 per participant (Amner, 2012), DBT saving of AUS $5,927 per patient over 6 months (Pasieczny & Connor, 2011), and MBCT saving of AUS $83 per depression-free day and AUS $87,313 per DALY averted from a health care perspective (Shawyer et al., 2016).
- Other full evaluations reported ICERs such as €66,450 per QALY gained for MBCT for medically unexplained symptoms (health care perspective; van Ravesteijn et al., 2013) and $33,579 per QALY gained for ACT versus a null comparator (health care perspective; Finnes et al., 2017).
Methods
- Systematic review following PRISMA and Cochrane guidance for narrative summary of health economic studies. Eight electronic databases (MEDLINE, MEDLINE In-Process, EMBASE, Web of Science, NHS EED, DARE, HTA, EconLit) were searched from inception to 22 November 2017, with no language restriction, plus hand-searching of reference lists.
- Full and partial economic evaluations of A/MBIs for adults with DSM-5 mental health disorders were eligible. Two reviewers independently screened records, data extraction was checked by a second reviewer, and methodological quality was assessed with the CHEC-list.
- A narrative synthesis summarized study characteristics, quality, and findings; no meta-analysis was performed.
Limitations
- The paper states that heterogeneity of included populations, interventions, and economic evaluation study types limits the extent to which firm conclusions can be made, and that more research is needed before firm conclusions can be reached on cost-effectiveness.
- The paper notes that not all studies presented incremental analyses, those that did used different willingness-to-pay thresholds, several evaluations depended on relatively small trials, and sensitivity analyses were often not clearly described. No economic models evaluating long-term cost-effectiveness were identified.
- Evident from the text: three included studies were partial economic evaluations with weaker quality assessment scores, DBT was assessed only in EUPD, and one study (Shawyer et al., 2016) did not discount outcomes despite a 24-month time horizon.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 94 cited sources checked · 0 supported · 0 flagged
- Findingown data
The A/MBIs subjected to economic evaluation were ACT, DBT, MBCT, and MBSR.
“The A/MBIs that had been subjected to economic evaluation were acceptance and commitment therapy (ACT), dialectical behaviour therapy (DBT), mindfulness‐based cognitive therapy (MBCT), and mindfulness‐based stress reduction (MBSR).”
Quote in the paperNot a substantial claim - Findingown data
Cost-effectiveness evaluation of A/MBIs has been more focused on depression and emotional unstable personality disorder, with three and four economic evaluations respectively.
“In terms of clinical presentations, the evaluation of cost‐effectiveness of A/MBIs has been more focused on depression and emotional unstable personality disorder with three and four economic evaluations, respectively.”
- Also stated in: § Practitioner points · plain
“Evidence relating to the cost‐effectiveness and cost‐saving potential of acceptance and mindfulness‐based interventions is focused mainly on depression and emotional unstable personality disorder to date.”
Quote in the paperNot a substantial claim - Also stated in: § Practitioner points · plain
- Findingown data
Ten relevant economic evaluations presented in 11 papers were identified.
“Ten relevant economic evaluations presented in 11 papers were identified.”
- Also stated in: § Results · plain
“The remaining 10 studies presented in 11 articles formed the final set of reviewed evidence”
Quote in the paperSubstantial claim- Rests on an assumption: The systematic search identified all available economic evidence of A/MBIs for the management of mental health conditions.
- Also stated in: § Results · plain
- Findingown data
Three included studies were partial economic evaluations (only costs considered).
“three studies were partial economic evaluations (i.e., only costs were considered in the analysis)”
Quote in the paperNot a substantial claim - Findingown data
Seven of the included studies were full economic evaluations (costs and effects assessed).
“Seven of the included studies were full economic evaluations (i.e., costs and effects assessed)”
Quote in the paperNot a substantial claim
- Findingnone given
The number of health economic evaluations relating to A/MBIs remains relatively small.
“The number of health economic evaluations relating to acceptance and mindfulness‐based interventions remains relatively small.”
Quote in the paperSubstantial claim - Findingown data
Three out of seven full economic evaluations observed that A/MBIs were cost-effective for the management of mental health conditions.
“Three out of seven full economic evaluations observed that A/MBIs were cost‐effective for the management of mental health conditions.”
Quote in the paperSubstantial claim - Findingown data
Seven of the 10 included studies adopted a societal perspective.
“Seven of the 10 studies adopted a societal perspective, in which all costs and benefits associated with the interventions in question were taken into account, irrespective of what entity they accrued to”
Quote in the paperNot a substantial claim - Findingcitation
van Ravesteijn et al. (2013) found an ICER of €66,450 per QALY gained from the health care system perspective.
“Health care system perspective: ICER of €66,450 per QALY gained”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Ravesteijn et al. (2013)
Not checked in the free run.
- Findingcitation
Pasieczny and Connor (2011) found that DBT resulted in a saving of $5927 per patient when compared to UC.
“DBT resulted in a saving of $5927 per patient when compared to UC”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pasieczny and Connor (2011)
Not checked in the free run.
- Findingnone given
The resource use and effectiveness data that informed the economic evaluations were derived from single studies.
“The resource use and effectiveness data that informed the economic evaluations were derived from single studies.”
Quote in the paperNot a substantial claim - Findingcitation
Kuyken et al. (2008) found an ICER of $439 per relapse/recurrence prevented from the health care system perspective.
“Health care system perspective: ICER $439 per relapse/recurrence prevented; ICER $23 per depression‐free day”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kuyken et al. (2008)
Not checked in the free run.
- Findingcitation
Kuyken et al. (2008) reported a 42% probability that MBCT plus antidepressant tapering is cost-effective based on a society's willingness to pay of zero to prevent an additional relapse/recurrence.
“Kuyken et al. (2008) reporting a 42% probability of MBCT plus antidepressant tapering being cost‐effective based on a society's willingness to pay (WTP) of zero to prevent an additional relapse/recurrence”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kuyken et al. (2008)
Not checked in the free run.
- Findingcitation
Priebe et al. (2012) found £36 to achieve a one percentage point reduction in the incidence of self-harm as a result of using DBT.
“£36 to achieve a one percentage point reduction in the incidence of self‐harm as a result of using DBT”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Priebe et al. (2012)
Not checked in the free run.
- Findingcitation
Wagner et al. (2014) found total mean annual EUPD-related societal cost-of-illness was €28,026 during pre-treatment, €18,758 during the DBT treatment year and €14,750 during the follow-up year.
“Total mean annual EUPD‐related societal cost‐of‐illness was €28,026 during pre‐treatment, €18,758 during the DBT treatment year and €14,750 during the follow‐up year”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wagner et al. (2014)
Not checked in the free run.
- Findingcitation
Shawyer et al. (2016) found a saving of AUS $87,313 per person per year by averting a DALY from the health care system perspective.
“MBCT produced a saving of AUS $87,313 per person per year by averting a DALY”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shawyer et al. (2016)
Not checked in the free run.
- Findingown data
No economic models evaluating the long-term cost-effectiveness of A/MBIs were identified.
“No economic models evaluating the long‐term cost‐effectiveness of A/MBIs were identified.”
Quote in the paperSubstantial claim - Findingcitation
Shawyer et al. (2016) reported an 83% probability that MBCT is cost-effective compared with usual care from a mental health care perspective.
“Shawyer et al. (2016) reporting a 83% probability of MBCT being cost‐effective compared to usual care, from a mental health care perspective”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shawyer et al. (2016)
Not checked in the free run.
- Findingcitation
Amner (2012) found that DBT results in a cost-saving of £36,551 between Years 1 and 3 as a result of reduced health service use.
“DBT results in a cost‐saving of £36,551 between Years 1 (prior to DBT) and 3 (after DBT) as a result of reduced health service use”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Amner (2012)
Not checked in the free run.
- Findingcitation
Finnes et al. (2017) found that ACT results in an ICER of $33,579 per additional QALY gained compared with the 'null comparator' from the health care perspective.
“Health care perspective: ACT results in an ICER of $33,579 per additional QALY gained compared with the ‘null comparator’”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Finnes et al. (2017)
Not checked in the free run.
- Findingcitation
van Ravesteijn et al. (2013) reported a 57% probability of cost-effectiveness against a willingness-to-pay threshold of EUR 80,000 per QALY for MBCT for participants with medically unexplained symptoms.
“The study investigating the impact of MBCT for participants with medically unexplained symptoms reported a 57% probability of cost‐effectiveness against a WTP threshold of EUR 80,000 per quality‐adjusted life year (QALY) (van Ravesteijn et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Ravesteijn et al. (2013)
Not checked in the free run.
- Findingcitation
Finnes et al. (2017) found that ACT for mental health disorders had a 75% probability of being cost-effective at a willingness-to-pay threshold of $14,000 per unit health gain.
“ACT for mental health disorders was found to have a probability of being cost‐effective of 75% at a WTP of $14,000 per unit health gain (Finnes et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Finnes et al. (2017)
Not checked in the free run.
- Findingcitation
Knight et al. (2015) observed a reduction in mean insurance costs per case treated for MBSR for mental health disorders.
“An assessment of MBSR also for mental health disorders observed a reduction in mean insurance costs per case treated (Knight et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Knight et al. (2015)
Not checked in the free run.
- Findingcitation
Wagner et al. (2014) observed a reduction in societal cost-of-illness in the year after the DBT intervention.
“The cost comparison by Wagner et al. (2014) observed a reduction in societal cost‐of‐illness in the year after the intervention.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wagner et al. (2014)
Not checked in the free run.
- Findingcitation
Kuyken et al. (2008) reported a higher probability of cost-effectiveness if the willingness-to-pay threshold to prevent an additional relapse/recurrence was set at a minimum of $1,000.
“The authors report that there was a higher probability of cost‐effectiveness, if the WTP threshold to prevent an additional relapse/recurrence was set at a minimum of $1,000.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kuyken et al. (2008)
Not checked in the free run.
- Findingcitation
Amner (2012) found that DBT had a positive impact on cost with an average saving per patient of £1,741 based on the year prior to intervention and the year following DBT.
“The partial evaluation by Amner (2012) found that DBT had a positive impact on cost with an average saving per patient of £1,741 based on the year prior to intervention and the year following DBT.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Amner (2012)
Not checked in the free run.
- Findingcitation
Kuyken et al. (2008) produced an inconclusive result regarding cost-effectiveness.
“The study by Kuyken et al. (2008) produced an inconclusive result regarding cost‐effectiveness”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kuyken et al. (2008)
Not checked in the free run.
- Findingcitation
One study concluded that MBCT was not cost-effective (Kuyken et al., 2015a, 2015b).
“One study concluded that MBCT was not cost‐effective (Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al., 2015a; Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Morant, et al., 2015b)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a)
Not checked in the free run.
- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Morant, et al. (2015b)
Not checked in the free run.
- Findingreasoning
The three studies assessing the impact of MBCT on patients with major depressive disorder yielded a variable set of cost-effectiveness results.
“The three studies assessing the impact of MBCT on patients with major depressive disorder yielded a variable set of cost‐effectiveness results.”
Quote in the paperSubstantial claim - Findingcitation
The remaining two studies (Pasieczny & Connor, 2011; Priebe et al., 2012) presented inconclusive results as to the cost-effectiveness of A/MBIs.
“the remaining two studies (Pasieczny & Connor, 2011; Priebe et al., 2012) presented inconclusive results as to the cost‐effectiveness of A/MBIs.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Pasieczny & Connor, 2011
Not checked in the free run.
- cites Priebe et al., 2012
Not checked in the free run.
- Findingown data
Not all included studies presented an incremental analysis.
“Not all studies presented an incremental analysis, and those that did present an incremental analysis used different WTP thresholds per QALY gain or improvement in outcomes assessed”
Quote in the paperSubstantial claim - Findingown data
Among included studies that presented an incremental analysis, different willingness-to-pay thresholds per QALY gain or improvement in outcomes were used.
“Not all studies presented an incremental analysis, and those that did present an incremental analysis used different WTP thresholds per QALY gain or improvement in outcomes assessed”
Quote in the paperSubstantial claim - Findingown data
A total of 10 economic evaluations of A/MBIs were included in the review.
“A total of 10 economic evaluations of A/MBIs were included in this review.”
Quote in the paperSubstantial claim - Findingcitation
Three studies (Finnes et al., 2017; Shawyer et al., 2016; van Ravesteijn et al., 2013) considered A/MBIs to be cost-effective when compared to the respective comparator treatments.
“Three studies (Finnes et al., 2017; Shawyer et al., 2016; and van Ravesteijn et al., 2013) considered A/MBIs to be cost‐effective when compared to the respective comparator treatments.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Finnes et al., 2017
Not checked in the free run.
- cites Shawyer et al., 2016
Not checked in the free run.
- cites van Ravesteijn et al., 2013
Not checked in the free run.
- Findingown data
Four studies evaluated the health economic impact of DBT on patients with EUPD.
“The review identified four studies that evaluated the health economic impact of DBT on patients with EUPD.”
Quote in the paperNot a substantial claim - Findingcitation
Shawyer et al. (2016) evaluation of MBCT combined with depressive relapse monitoring yielded a strong result with regard to cost-effectiveness versus depressive relapse monitoring alone.
“the evaluation by Shawyer et al. (2016) into MBCT combined with depressive relapse monitoring yielded a strong result with regard to cost‐effectiveness of this integrated approach versus the comparator treatment of depressive relapse monitoring alone.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shawyer et al. (2016)
Not checked in the free run.
- Findingcitation
Pasieczny and Connor (2011) did not conduct an incremental analysis of DBT.
“Whilst Pasieczny and Connor (2011) did not conduct an incremental analysis of DBT”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pasieczny and Connor (2011)
Not checked in the free run.
- Findingcitation
Finnes et al. (2017) reported a 75% probability of ACT being cost-effective when compared to doing nothing at a willingness-to-pay threshold of $14,000 per QALY gained.
“Finnes et al. (2017) reported a 75% probability of ACT being cost‐effective when compared to doing nothing at a willingness‐to‐pay threshold of $14,000 per QALY gained.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Finnes et al. (2017)
Not checked in the free run.
- Findingcitation
van Ravesteijn et al. (2013) evaluating MBCT for the treatment of medically unexplained symptoms reported that the probability of cost-effectiveness was 55% assuming a willingness-to-pay of €80,000 per QALY gained.
“the study by van Ravesteijn et al. (2013) evaluating MBCT for the treatment of medically unexplained symptoms reported that the probability of cost‐effectiveness was 55% assuming a WTP of €80,000 per QALY gained.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Ravesteijn et al. (2013)
Not checked in the free run.
- Findingown data
Seven of the papers included in the review adopted a societal perspective.
“Seven of the papers included in this review adopted a societal perspective”
Quote in the paperNot a substantial claim - Findingown data
Five of the included studies presented a set of results from both a societal and a health and personal social care perspective.
“five of the studies included presented a set of results from both a societal and a health and personal social care perspective.”
Quote in the paperNot a substantial claim - Findingown data
There was large variability across the included studies in how successfully all relevant costs were sourced and measured.
“The current review indicated that there was large variability across the studies to how successful this had been executed.”
Quote in the paperNot a substantial claim - Findingcitation
Amner (2012), due primarily to data availability issues, only included mental health service resource use.
“For example, Amner (2012), due primarily to data availability issues, only included mental health service resource use.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Amner (2012)
Not checked in the free run.
- Findingcitation
The three studies that focused on the cost-effectiveness of MBCT for the treatment of depression had a comprehensive set of costs assumed within the analysis.
“For example, the three studies that focused on the cost‐effectiveness of MBCT for the treatment of depression had a comprehensive set of costs assumed within the analysis”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Kuyken, et al., 2008
Not checked in the free run.
- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a)
Not checked in the free run.
- cites Shawyer et al., 2016
Not checked in the free run.
- Findingreasoning
An additional potential source of heterogeneity was the inclusion of economic evaluations assessing diverse forms of A/MBIs including MBCT, ACT, and DBT.
“An additional potential source of heterogeneity was the inclusion of economic evaluations assessing diverse forms of A/MBIs including MBCT, ACT, and DBT.”
Quote in the paperNot a substantial claim - Findingown data
DBT was only assessed in relation to EUPD.
“It is important to note that DBT was only assessed in relation to EUPD.”
Quote in the paperSubstantial claim - Findingnone given
The available economic evaluations varied in terms of study population, intervention type, and economic evaluation methods.
“The available economic evaluations varied in terms of study population, intervention type, and the economic evaluation methods.”
Quote in the paperSubstantial claim - Premisecitation
The evidence base on the cost-effectiveness of A/MBIs is sparse.
“the economic case for these interventions has not been fully explored.”
- Also stated in: § Background · plain
“the evidence base on the cost‐effectiveness of such interventions is sparse (Edwards, Bryning, & Crane, 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Edwards, Bryning, & Crane, 2015
Not checked in the free run.
- Also stated in: § Background · plain
- Interpretationreasoning
Heterogeneity in the specific forms of A/MBIs may limit generalizability of the findings.
“Heterogeneity in the specific forms of acceptance and mindfulness‐based interventions may limit generalizability of the findings.”
Quote in the paperSubstantial claim - Interpretationreasoning
Heterogeneity of included populations, interventions, and economic evaluation study types limits the extent to which firm conclusions can currently be made.
“Nevertheless, the heterogeneity of included populations, interventions, and economic evaluation study types limits the extent to which firm conclusions can currently be made.”
Quote in the paperSubstantial claim - Premisecitation
Despite available evidence and NICE guidance, a relatively low number of mental health services in the United Kingdom had systematically implemented the MBCT recommendation.
“However, an assessment of the uptake of MBCT in the United Kingdom showed that despite the available evidence and NICE guidance, a relatively low number of mental health services had systematically implemented the recommendation (Crane & Kuyken, 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Crane & Kuyken, 2013
Not checked in the free run.
- Premisecitation
MBCT is effective for recurrent depression compared with usual care and maintenance antidepressants.
“Several studies have found MBCT to be effective for recurrent depression compared with usual care and maintenance antidepressants (Kuyken et al., 2008, 2016; Ma & Teasdale, 2004; Piet & Hougaard, 2011; Teasdale et al., 2000).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Kuyken et al., 2008, 2016
Not checked in the free run.
- cites Ma & Teasdale, 2004
Not checked in the free run.
- cites Piet & Hougaard, 2011
Not checked in the free run.
- Interpretationcitation
The role of MBCT in the management of depression has not yet been fully implemented in routine practice.
“These findings suggest that the role of MBCT in the management of depression has not yet been fully implemented in routine practice.”
Quote in the paperSubstantial claim - Interpretationreasoning
None of the four DBT/EUPD studies provided convincing evidence to support a hypothesis that A/MBIs are a cost-effective treatment, due in part to economic evaluation design and uncertainty around results.
“None of these studies provided convincing evidence to support a hypothesis that A/MBIs are a cost‐effective treatment, due in part to economic evaluation design and uncertainty around results.”
Quote in the paperSubstantial claim - Interpretationreasoning
The results arising from the three studies fail to provide conclusive evidence that MBCT is a cost-effective treatment for depression.
“In summary, the results arising from the three studies fail to provide conclusive evidence that MBCT is a cost‐effective treatment for depression.”
Quote in the paperSubstantial claim - Interpretationreasoning
Given the small sample sizes, limited scope of cost, and broad approach to sensitivity analysis, the results of Amner (2012) and Wagner et al. (2014) can be viewed as uncertain.
“Furthermore, given the small sample sizes, limited scope of cost, and a broad approach to sensitivity analysis, the results can be viewed as uncertain.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Amner (2012)
Not checked in the free run.
- cites Wagner et al. (2014)
Not checked in the free run.
- Premisecitation
There is evidence supporting the use of generic quality-of-life measures to evaluate interventions for common mental health problems such as depression and anxiety.
“There is evidence supporting the use of generic QoL measures to evaluate interventions for common mental health problems (e.g., depression and anxiety)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mulhern et al., 2014
Not checked in the free run.
- Interpretationreasoning
The time horizons adopted in these studies provided a useful base to capture the effect of the A/MBI, congruent with Medical Research Council guidance.
“Given the multi‐dimensional nature of an A/MBI, the time horizons adopted in these studies provided a useful base to capture the effect of the A/MBI, congruent with Medical Research Council guidance (Craig et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Craig et al., 2008
Not checked in the free run.
- Interpretationreasoning
The heterogeneity of included populations, interventions, and economic evaluation study types limits the extent to which firm conclusions can be made in relation to different clinical conditions.
“the heterogeneity of included populations, interventions, and economic evaluation study types limits the extent to which firm conclusions can be made in relation to different clinical conditions.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 22
- May combine two claims. 36
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSensitivity analyses feature in four of the full economic evaluations as a way of dealing with uncertainty associated with a range of parameters.
“Sensitivity analyses feature in four of the full economic evaluations as a way of dealing with uncertainty associated with a range of parameters”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationKuyken et al. (2015a) found that in terms of QALYs, costs were higher in the MBCT group and outcomes slightly worse, suggesting that MBCT was dominated by maintenance antidepressant treatment.
“In terms of QALYs, costs were higher in the MBCT group and outcomes slightly worse, suggesting that MBCT was dominated by maintenance antidepressant treatment”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kuyken, et al. (2015a)
Not checked in the free run.
May combine two claims.
Findingown dataKnight et al. (2015) was a partial economic evaluation and met fewer quality assessment criteria than the full economic evaluations.
“However, the study by Knight et al. (2015) was a partial economic evaluation and met a lesser number of criteria in the quality assessment than the full economic evaluations.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Knight et al. (2015)
Not checked in the free run.
May combine two claims.
FindingcitationPriebe et al. (2012) reported a modest incremental cost of £36 to achieve a one percentage point reduction in the incidence of self-harm, with no explicit statement on the probability of cost-effectiveness.
“Priebe et al. (2012) reporting a modest incremental cost of £36 to achieve a one percentage point reduction in the incidence of self‐harm; however, no explicit statement on the probability of cost‐effectiveness was reported.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Priebe et al. (2012)
Not checked in the free run.
May combine two claims.
FindingcitationPasieczny and Connor (2011) reported a positive impact of DBT on both cost and outcomes, with a mean saving of AUS $5,927 per patient over a 6-month period and a mean reduction in suicide attempts of 1.34 per patient.
“Pasieczny and Connor (2011) adopting a CCA approach reported a positive impact of DBT on both cost and outcomes, with a mean saving of AUS $5,927 per patient over a 6‐month period and mean reduction in suicide attempts of 1.34 per patient, respectively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pasieczny and Connor (2011)
Not checked in the free run.
May combine two claims.
Findingown dataAmner (2012) and Wagner et al. (2014) were partial economic evaluations and met fewer quality assessment criteria than the other studies assessing DBT for EUPD.
“However, these studies (Amner, 2012; Wagner et al., 2014) were partial economic evaluations and met a lesser number of criteria in the quality assessment than the other studies assessing DBT for EUPD.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Amner, 2012
Not checked in the free run.
- cites Wagner et al., 2014
Not checked in the free run.
May combine two claims.
FindingcitationIn Kuyken et al. (2008), the use of MBCT was considered justified only if the willingness to pay for improvements in the proportion of patients who relapse was $1,000 or above, and results were considered inconclusive.
“In the study by Kuyken et al. (2008), the use of MBCT was considered to be justified but only if the WTP for improvements in the proportion of patients who relapse was $1,000 or above and results were considered inconclusive.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kuyken et al. (2008)
Not checked in the free run.
May combine two claims.
FindingcitationKuyken et al. (2015a) reported that the MBCT group resulted in more costs and less effectiveness than the maintenance antidepressant treatment group.
“the more recent study by Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a) reported that the MBCT group resulted in more costs and less effectiveness than maintenance antidepressant treatment group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a)
Not checked in the free run.
May combine two claims.
FindingreasoningIn Amner (2012) and Wagner et al. (2014), there was no assessment of health outcomes and pre-intervention data were collected retrospectively.
“there was no assessment of health outcomes and pre‐intervention data were collected retrospectively.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Amner (2012)
Not checked in the free run.
- cites Wagner et al. (2014)
Not checked in the free run.
May combine two claims.
Findingown dataKuyken et al. (2015a) and Shawyer et al. (2016) are similar in terms of criteria met in the quality assessment; however, Shawyer et al. (2016) did not discount outcomes as recommended for economic evaluations with a time horizon longer than 12 months.
“The studies by Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a) and Shawyer et al. (2016) are similar in terms of the criteria met in the quality assessment; however, the study by Shawyer et al. (2016) did not discount the outcomes as recommended it should be done in economic evaluations with a time horizon longer than 12 months.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a)
Not checked in the free run.
- cites Shawyer et al. (2016)
Not checked in the free run.
May combine two claims.
FindingcitationParticipants in the intervention arm of Shawyer et al. (2016) spent less time on average in a major depressive state and incurred less DALYs relative to comparator treatment.
“participants in the intervention arm of the trial spent less time, on average, in a major depressive state and as result incurred less DALYs relative to the comparator treatment (Shawyer et al., 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shawyer et al. (2016)
Not checked in the free run.
May combine two claims.
FindingcitationAmner (2012) and Wagner et al. (2014) reported that the cost of treating participants with EUPD reduced after DBT intervention when compared with treatment prior to DBT.
“whilst both the studies by Amner (2012) and Wagner et al. (2014) reported that the cost of treating participants with EUPD reduced after DBT intervention when compared with treatment prior to DBT”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Amner (2012)
Not checked in the free run.
- cites Wagner et al. (2014)
Not checked in the free run.
May combine two claims.
FindingcitationThe findings indicated either marginal borderline evidence that MBCT reduced the risk of relapse of a depressive episode relative to comparator treatment (Kuyken et al., 2008), or no difference at all (Kuyken et al., 2015a, 2015b).
“The findings also indicated either marginal borderline evidence that MBCT reduced the risk of relapse of a depressive episode relative to the comparator treatment (Kuyken et al., 2008), or no difference at all (Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al., 2015a; Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Morant, et al., 2015b).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Kuyken et al., 2008
Not checked in the free run.
- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a)
Not checked in the free run.
- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Morant, et al. (2015b)
Not checked in the free run.
May combine two claims.
FindingcitationPasieczny and Connor (2011) revealed that participants consumed fewer health and social care resources on the DBT arm of the trial and benefited from better health outcomes on the back of reduced incidence of suicide attempts.
“the study revealed that participants consumed fewer health and social care resources on the DBT arm of the trial and benefited from better health outcomes on the back of reduced incidence of suicide attempts.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pasieczny and Connor (2011)
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
FindingcitationThe level of uncertainty around the cost impact of the intervention led the authors of Priebe et al. (2012) to conclude that while DBT was shown to be effective in reducing the incidence of self-harm, there was a possibility for higher treatment costs overall.
“The level of uncertainty around the cost impact of the intervention led the authors to conclude that whilst DBT was shown to be effective in reducing the incidence of self‐harm, there was a possibility for higher treatment costs overall.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Priebe et al. (2012)
Not checked in the free run.
May combine two claims.
FindingcitationPriebe et al. (2012) evidenced a reduction in self-harm in participants receiving DBT intervention arm compared to the treatment as usual arm, and the mean cost per patient of the DBT intervention was higher than the comparator, albeit not statistically significant.
“the study of Priebe et al. (2012) evidenced a reduction in self‐harm in participants receiving DBT intervention arm compared to the treatment as usual arm, and the mean cost per patient of the DBT intervention was higher than the comparator, albeit not statistically significant.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Priebe et al. (2012)
Not checked in the free run.
May combine two claims.
Findingnone givenNine of the ten studies had a study time horizon of 12 months or more, with two of the three studies assessing MBCT for depression having a 24-month follow-up.
“It is positive that nine of the ten studies had a study time horizon of 12 months or more, with two of the three studies assessing MBCT for depression having a 24‐month follow‐up.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenThe identified studies employed a variety of measures to capture positive changes in mental health outcomes and improved health-related quality of life, with the latter being translated into QALYs.
“the identified studies employed a variety of measures to capture positive changes in mental health outcomes and improved health‐related quality of life, with the latter being translated into QALYs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Findingnone givenThis is the first review to systematically synthesize research evidence relating to the cost-effectiveness of A/MBIs.
“This is the first review to systematically synthesize research evidence relating to the cost‐effectiveness of A/MBIs.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSix of the ten studies were reported to have undertaken sensitivity analysis to test various parameter uncertainties, but the data and methods used to characterize the level of uncertainty were either not described or not clearly detailed.
“whilst six of the ten studies were reported to have undertaken sensitivity analysis to test various parameter uncertainties, the data and methods used to characterize the level of uncertainty were either not described or not clearly detailed.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe Kuyken et al. (2015a) study superseded the Kuyken et al. (2008) study and found the intervention not to be cost-effective.
“This has been superseded by the study of Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a), which found the intervention not to be cost‐effective.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a)
Not checked in the free run.
- cites Kuyken et al. (2008)
Not checked in the free run.
May combine two claims.
Findingown dataThree out of seven full economic evaluations suggest A/MBIs to be cost-effective, while the three partial economic evaluations considered A/MBIs to be cost-saving versus a range of comparator interventions.
“Three out of seven full economic evaluations suggest A/MBIs to be cost‐effective, whilst the three partial economic evaluations considered A/MBIs to be cost‐saving versus a range of comparator interventions.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe results of the included economic evaluations varied with one study suggesting A/MBIs not to be cost-effective while other studies were inconclusive.
“The results of the included economic evaluations varied with one study suggesting A/MBIs not to be cost‐effective whilst other studies were inconclusive.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMBSR and MBCT significantly improved depressive symptoms, anxiety, stress, and physical functioning for patients with cancer, chronic pain, cardiovascular disease, somatic diseases, and depression compared to waiting list control and treatment as usual.
“An overview of systematic review and meta‐analysis of randomized control trials (RCTs) found that MBSR and MBCT significantly improved depressive symptoms, anxiety, stress, and physical functioning for patients with cancer, chronic pain, cardiovascular disease, somatic diseases, and depression when compared to waiting list control and to treatment as usual (Gotink et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gotink et al., 2015
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningMore research is needed before firm conclusions can be reached on the cost-effectiveness of A/MBIs for mental health conditions.
“This first substantive review of economic evaluations of A/MBIs indicates that more research is needed before firm conclusions can be reached on the cost‐effectiveness of A/MBIs for mental health conditions.”
- Also stated in: § Conclusion · plain
“More research is needed before firm conclusions can be reached on the cost‐effectiveness of A/MBIs for mental health conditions.”
Quote in the paperSubstantial claim- Also stated in: § Conclusion · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMBCT is recommended in the United Kingdom as an approach to prevent depressive relapse among patients with three prior episodes of depression.
“MBCT as an approach to prevent depressive relapse among patients with three prior episodes of depression is recommended in the United Kingdom (NICE 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites NICE 2009
Not checked in the free run.
May combine two claims.
PremisecitationDBT is effective in reducing self-destructive behaviours and enhancing treatment adherence.
“A meta‐analysis indicated that DBT was effective in reducing self‐destructive behaviours and enhancing the extent to which participants adhered to treatment (Panos, Jackson, Hasan, & Panos, 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Panos, Jackson, Hasan, & Panos, 2014
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe methodological quality of included economic evaluations was assessed using the CHEC-list.
“The methodological quality of the economic evaluations identified was assessed using the Consensus on Health Economic Criteria checklist (CHEC‐list) (Evers, Goossens, de Vet, van Tulder, & Ament, 2005), which is recommended for appraising the methodological quality of economic evaluations (Higgins & Green, 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Evers, Goossens, de Vet, van Tulder, & Ament, 2005
Not checked in the free run.
- cites Higgins & Green, 2011
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThis systematic review follows PRISMA reporting guidelines and Cochrane Handbook recommendations for narrative summary of health economic studies.
“This systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) reporting guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009) and the good practice recommendations for narrative summary of health economic studies outlined in the Cochrane Handbook for Systematic Reviews (Shemilt et al., 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Moher, Liberati, Tetzlaff, & Altman, 2009
Not checked in the free run.
- cites Shemilt et al., 2011
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationACT offers promise to reduce distress associated with a range of physical and mental health difficulties.
“Similarly, a meta‐analysis of ACT studies concluded that ACT offers promise to reduce distress associated with a range of physical and mental health difficulties (A‐tjak et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites A‐tjak et al., 2015
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenOne author extracted data, and a second author checked the data for accuracy.
“One author extracted the data, and a second author checked the data for accuracy.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTwo reviewers independently assessed all records based on title and abstract according to inclusion criteria.
“Two reviewers independently assessed all records based on their title and abstract according to the inclusion criteria (Table 1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenQuality assessment was carried out by one reviewer and checked for agreement by a second reviewer.
“Quality assessment was carried out by one reviewer and checked for agreement by a second reviewer.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA/MBIs are complex psycho-social treatment packages with interrelated components that have a synergizing effect.
“As with other forms of complex intervention, A/MBIs are complex psycho‐social treatment packages with interrelated components that have a synergizing effect (Demarzo et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Demarzo et al., 2015
Not checked in the free run.
May combine two claims.
Interpretationnone givenvan Ravesteijn et al. (2013) used a willingness-to-pay threshold of €80,000 per QALY gained, which is higher than the willingness-to-pay per QALY gained in other countries.
“However, van Ravesteijn et al. (2013) used a WTP of €80,000 per QALY gained, which is higher than the WTP per QALY gained in other countries.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Ravesteijn et al. (2013)
Not checked in the free run.
May combine two claims.
InterpretationcitationThe results relating to cost in Pasieczny and Connor (2011) have a degree of uncertainty, as the mean reduction of AUS $5,927 per patient on the DBT arm related specifically to a 6-month time horizon, and the authors reported the intervention group to be more costly than the comparator treatment group for those patients who continued to receive the intervention for a further 6 months.
“However, the results relating to cost have a degree of uncertainty, as the mean reduction of AUS $5,927 per patient on the DBT arm related specifically to a 6‐month time horizon, and the authors reported the intervention group to be more costly than the comparator treatment group for those patients who continued to receive the intervention for a further 6 months.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pasieczny and Connor (2011)
Not checked in the free run.
May combine two claims.
InterpretationreasoningTwo evaluations focusing on MBCT's effect on depression (Kuyken et al., 2008; Kuyken et al., 2015a; Kuyken et al., 2015b) presented results from both societal and health/personal social care perspectives, strengthening their external validity from this perspective.
“Indeed, it is noteworthy that two of evaluations focusing on MBCT's effect on depression (Kuyken, et al., 2008; Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al., 2015a; Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Morant, et al., 2015b) presented results in this way, thus strengthening their external validity from this perspective.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Kuyken, et al., 2008
Not checked in the free run.
- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a)
Not checked in the free run.
- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Morant, et al. (2015b)
Not checked in the free run.
May combine two claims.
InterpretationreasoningIn Priebe et al. (2012), the incremental cost to achieve a one percentage point reduction in the incidence of self-harm was relatively low, but the small sample size and lack of statistical power to yield a statistically significant difference in cost create a level of uncertainty around cost-effectiveness, which was not explored by the authors.
“So whilst the incremental cost to achieve a one percentage point reduction in the incidence of self‐harm was relative low, the small sample size and lack of statistical power to yield a statistically significant difference in cost create a level of uncertainty around cost‐effectiveness, which was not explored by the authors.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Priebe et al. (2012)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenIt is difficult to draw any direct comparisons between the remaining three studies that evaluated the impact of A/MBIs on non-specific mental health conditions.
“It is difficult to draw any direct comparisons between the remaining three studies that evaluated the impact of A/MBIs on non‐specific mental health conditions.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationEmpirical evidence suggests that psychological well-being and social interaction are salient elements for people with mental health problems, though such elements are not included in prominent generic measures of quality of life, which instead focus on domains such as usual activities, physical mobility, and pain.
“empirical evidence suggests that psychological well‐being and social interaction are salient elements for people with mental health problems, though such elements are not included in prominent generic measures of QoL, which instead focus on domains such as usual activities, physical mobility, and pain (Chisholm, Healey, & Knapp, 1997).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chisholm, Healey, & Knapp, 1997
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationQALYs offer a generic measure of quality of life that can facilitate comparisons across areas and conditions, including mental health problems.
“QALYs offer a generic measure of quality of life (QoL) that can facilitate comparisons across areas and conditions, including mental health problems (Brazier, 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brazier, 2008
Not checked in the free run.
May combine two claims.
Interpretationown dataWith the exception of Kuyken et al. (2015a) and Shawyer et al. (2016), the economic evaluations in the review were dependent on the results of relatively small trials, which may affect the internal validity of the results.
“With the exception of the Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a) and Shawyer et al. (2016) studies, the economic evaluations in the current review were dependent on the results of relatively small trials, which may affect the internal validity of the results.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al. (2015a)
Not checked in the free run.
- cites Shawyer et al. (2016)
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe study parameters were wide in scope, which successfully facilitated a search of literature to inform the knowledge base of cost-effectiveness of A/MBIs.
“The study parameters were therefore wide in scope, which successfully facilitated a search of literature to inform the knowledge base of cost‐effectiveness of A/MBIs.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThere were a number of technical issues with the three studies examining the cost-effectiveness of MBCT on depression, but there was a relatively high level of internal and external validity across these studies.
“whilst there were a number of technical issues with the three studies examining the cost‐effectiveness of MBCT on depression, there was a relatively high level of internal and external validity across these studies.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationEach part of the review, including study identification, selection, quality assessment, and data extraction, was carried out in line with PRISMA and Centre for Reviews and Dissemination guidelines.
“Each part of the review, including study identification, selection, quality assessment, and data extraction, was carried out in line with PRISMA (Moher et al., 2009) and Centre for Reviews and Dissemination guidelines (NHS CRD 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Moher et al., 2009
Not checked in the free run.
- cites NHS CRD 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationConsistent with previous reviews that have evaluated the efficacy of A/MBIs, the studies included in the current review focused on a range of conditions and interventions.
“Consistent with previous reviews that have evaluated the efficacy of A/MBIs, the studies included in the current review focused on a range of conditions (Gotink et al., 2015; Khoury et al., 2013) and interventions (Cavanagh et al., 2014; Veehof et al., 2016; Vøllestad et al., 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Gotink et al., 2015
Not checked in the free run.
- cites Khoury et al., 2013
Not checked in the free run.
- cites Cavanagh et al., 2014
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningAs the results are presented separately by mental health condition, the health economic evaluation for DBT can be easily disaggregated from the analyses relating to other forms of A/MBIs.
“As the results are presented separately by mental health condition, the health economic evaluation for DBT can be easily disaggregated from the analyses relating to other forms of A/MBIs.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenNo constraints were set on the economic study type and limited criteria on the population of interest.
“No constraints were set on the economic study type and limited criteria on the population of interest.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationNICE (2009) recommended MBCT as a treatment for people who are currently well but had experienced three or more previous depressive episodes.
“NICE (2009) recommended MBCT as a treatment for people who are currently well but had experienced three or more previous depressive episodes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites NICE (2009)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTwo recent reviews of MBIs have highlighted that there is a need to better monitor the quantity and quality of between-session mindfulness practice, which is purported to be an important process of change.
“Two recent reviews of MBIs have highlighted that there is a need to better monitor the quantity and quality of between‐session mindfulness practice, which is purported to be an important process of change (Lloyd, White, Eames, & Crane, 2017; Parsons, Crane, Parsons, Fjorback, & Kuyken, 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Lloyd, White, Eames, & Crane, 2017
Not checked in the free run.
- cites Parsons, Crane, Parsons, Fjorback, & Kuyken, 2017
Not checked in the free run.
May combine two claims.
PremisecitationNICE's decision was made based on one cost-effectiveness analysis (Kuyken et al., 2008), which produced an inconclusive result.
“This decision was made based on one cost‐effectiveness analysis (Kuyken et al., 2008), which produced an inconclusive result.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites NICE (2009)
Not checked in the free run.
- cites Kuyken et al., 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationGiven the relatively poor implementation of MBCT for depression, the findings of the review provide information that may be relevant to decision-makers responsible for implementation of the NICE guideline.
“Given the relatively poor implementation of MBCT for depression (Crane & Kuyken, 2013), the findings of the review provide information that may be relevant to decision‐makers responsible for implementation of this NICE guideline.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Crane & Kuyken, 2013
Not checked in the free run.
The paper relies on this without support.
The systematic search identified all available economic evidence of A/MBIs for the management of mental health conditions.
“The aim of this systematic review was to identify and appraise all available economic evidence of A/MBIs for the management of mental health conditions.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the context of ED, mindfulness may reduce anxiety, spectatoring, and self-evaluation and help redirect attention to physical and erotic sensations.
“In the context of ED, mindfulness may reduce anxiety, spectatoring, and self-evaluation and help to redirect attention to physical and erotic sensations instead of cognitive distractors.130”
From A Psychosocial Approach to Erectile Dysfunction: Position Statements from the European Society of Sexual Medicine (ESSM) (2021) · cites this paper as [130]
The Background (page unavailable) describes mindfulness as attention to the present moment and reports reduced anxiety in several patient groups. It does not address erectile dysfunction, spectatoring, self-evaluation, or redirecting attention to erotic sensations, so the ED-specific claim is unsupported. (LLM, conf=0.83)
Experimental — accuracy not yet measuredThere is still considerable uncertainty surrounding the cost-effectiveness of MBCT for management of mental health conditions including recurrent depression.
“This is of particular relevance for MBCT as recent systematic review of economic evaluations of acceptance and mindfulness-based interventions reported that there is still considerable uncertainty surrounding the cost-effectiveness of MBCT for management of mental health conditions including recurrent depression.55”
From Mindfulness-based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta-analysis (2021) · cites this paper as [55]
The fact that these treatments are performed in groups can make them more cost-effective, and therefore of interest for health managers.
“The fact that these treatments are performed in groups can make them more cost-effective, and therefore of interest for health managers.72”
From Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression: study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study) (2020) · cites this paper as [72]
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- ConsistentF(2, 78) = 25.14reported p < .001 · recomputed p < .001
“F(2, 78) = 25.14, p < .001”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Two probabilities reported for van Ravesteijn at the same threshold
MinorThe results narrative gives a 57% probability of cost-effectiveness at €80,000 per QALY, whereas Table 4 and the discussion give 55% at that threshold.
“reported a 57% probability of cost‐effectiveness against a WTP threshold of EUR 80,000 per quality‐adjusted life year (QALY) (van Ravesteijn et al., 2013).”
“The probability that MBCT is cost‐effective is 55% assuming a WTP of €80,000 for a QALY gain”
Cites
1 retracted
Gotink, R. A., Chu, P., Busschbach, J. J. V., Benson, H., Fricchione, G. L., & Hunink, M. G. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124344 · Cited by 539 · see citing works
RetractedDiagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554 · see citing works
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648 · see citing works
Developing and evaluating complex interventions: the new Medical Research Council guidance
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2008) · BMJ · doi:10.1136/bmj.a1655 · Cited by 10,995 · see citing works
Mindfulness-based interventions in context: Past, present, and future
Kabat-Zinn, J. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bpg016 · Cited by 8,615 · cited 3× · see citing works
“An assessment of MBSR also for mental health disorders observed a reduction in mean insurance costs per case treated (Knight et al., 2015). However, the study by Knight et al. (2015) was a partial economic evaluation and met a lesser number of criteria in the quality assessment than the full economic evaluations.”
BackgroundInfluentialMindfulness: A proposed operational definition.
Bishop, S. R., Lau, M., Shapiro, S., Carlson, L., Anderson, N. D., Carmody, J., Segal, Z. V., Abbey, S., Speca, M., Velting, D., et al. (2004) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bph077 · Cited by 7,234 · see citing works
Mindfulness training as a clinical intervention: a conceptual and empirical review
Baer, R. A. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bpg015 · Cited by 4,577 · see citing works
Systematic reviews: CRD's guidance for undertaking reviews in health care
Tacconelli, E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70065-7 · Cited by 3,237 · see citing works
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236 · see citing works
Mindfulness-based therapy: a comprehensive meta-analysis
Khoury, B., Lecomte, T., Fortin, G., Masse, M., Therien, P., Bouchard, V., Chapleau, M.-A., Paquin, K., & Hofmann, S. G. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.05.005 · Cited by 2,003 · see citing works
(2014) · Cited by 1,541 · see citing works
Ma, S. H., & Teasdale, J. D. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.1.31 · Cited by 1,390 · see citing works
A-Tjak, J. G. L., Davis, M. L., Morina, N., Powers, M. B., Smits, J. A. J., & Emmelkamp, P. M. G. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000365764 · Cited by 921 · see citing works
(1994) · Cited by 877 · see citing works
Evers, S., Goossens, M. E. J. B., de Vet, H. C. W., van Tulder, M. W., & Ament, A. J. H. A. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050324 · Cited by 860 · see citing works
Kuyken, W., Warren, F. C., Taylor, R. S., Whalley, B., Crane, C., Bondolfi, G., Hayes, R., Huijbers, M., Ma, H., Schweizer, S., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0076 · Cited by 821 · see citing works
Piet, J., & Hougaard, E. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.05.002 · Cited by 807 · see citing works
Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., Barrett, B., Byng, R., Evans, A., Mullan, E., et al. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013786 · Cited by 770 · see citing works
Veehof, M. M., Trompetter, H. R., Bohlmeijer, E. T., & Schreurs, K. M. G. (2016) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2015.1098724 · Cited by 737 · cited 1× · see citing works
“Consistentwith previous reviews that have evaluated the efficacy of A/MBIs, the studies included in the current review focused on a range of conditions (Gotink et al., 2015; Khoury et al., 2013) and interventions (Cavanagh et al., 2014; Veehof et al., 2016; Vøllestad et al., 2012).”
Acceptance and Commitment Therapy as a Unified Model of Behavior Change
Hayes, S. C., Pistorello, J., & Levin, M. E. (2012) · The Counseling Psychologist · doi:10.1177/0011000012460836 · Cited by 718 · see citing works
Parsons, C. E., Crane, C., Parsons, L. J., Fjorback, L. O., & Kuyken, W. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.05.004 · Cited by 550 · see citing works
Kuyken, W., Hayes, R., Barrett, B., Byng, R., Dalgleish, T., Kessler, D., Lewis, G., Watkins, E., Brejcha, C., Cardy, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62222-4 · Cited by 527 · see citing works
Vøllestad, J., Nielsen, M. B., & Nielsen, G. H. (2012) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.2011.02024.x · Cited by 459 · see citing works
Cavanagh, K., Strauss, C., Forder, L., & Jones, F. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.01.001 · Cited by 340 · see citing works
Meta-Analysis and Systematic Review Assessing the Efficacy of Dialectical Behavior Therapy (DBT)
Panos, P. T., Jackson, J. W., Hasan, O., & Panos, A. (2014) · Research on Social Work Practice · doi:10.1177/1049731513503047 · Cited by 299 · see citing works
Mindfulness-based interventions for binge eating: A systematic review and meta-analysis
Godfrey, K. M., Gallo, L. C., & Afari, N. (2015) · Journal of Behavioral Medicine · doi:10.1007/s10865-014-9610-5 · Cited by 284 · see citing works
The Noble Eightfold Path: Way to the End of Suffering
Bodhi, B. (2020) · Cited by 237 · see citing works
NICE Guide to the Methods of Technology Appraisal
Earnshaw, J., & Lewis, G. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826090-00002 · Cited by 228 · see citing works
[Solitary median maxillary central incisor syndrome:a case of report].
Kang, L.-Y., & Liu, X. (2014) · PubMed · Cited by 208 · see citing works
The Application of Mindfulness to Eating Disorders Treatment: A Systematic Review
Wanden-Berghe, R. G., Sanz-Valero, J., & Wanden-Berghe, C. (2010) · Eating Disorders · doi:10.1080/10640266.2011.533604 · Cited by 184 · see citing works
The efficacy of mindfulness-based interventions in primary care: a meta-analytic review.
Demarzo, M. M. P., Montero-Marin, J., Cuijpers, P., Zabaleta-del-Olmo, E., Mahtani, K. R., Vellinga, A., Vicens, C., Lopez-del-Hoyo, Y., & Garcia-Campayo, J. (2015) · The Annals of Family Medicine · doi:10.1370/afm.1863 · Cited by 152 · see citing works
Priebe, S., Bhatti, N., Barnicot, K., Bremner, S. A., Gaglia, A., Katsakou, C., Mosweu, I., McCrone, P., & Zinkler, M. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000338897 · Cited by 150 · see citing works
Fuchs, C., Lee, J. K., Roemer, L., & Orsillo, S. M. (2013) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2011.12.004 · Cited by 139 · see citing works
Mulhern, B. J., Mukuria, C., Barkham, M., Knapp, M. R. J., Byford, S., Soeteman, D., & Brazier, J. E. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.122283 · Cited by 134 · see citing works
Pots, W. T. M., Fledderus, M., Meulenbeek, P. A. M., ten Klooster, P. M., Schreurs, K. M. G., & Bohlmeijer, E. T. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.146068 · Cited by 133 · see citing works
Brazier, J. E., Tumur, I., Holmes, M. C., Ferriter, M., Parry, G. D., Dent-Brown, K., & Paisley, S. (2006) · Health Technology Assessment · doi:10.3310/hta10350 · Cited by 131 · see citing works
Chisholm, D., Healey, A., & Knapp, M. R. J. (1997) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788923 · Cited by 127 · see citing works
Crane, R. S., & Kuyken, W. (2013) · Mindfulness · doi:10.1007/s12671-012-0121-6 · Cited by 120 · see citing works
Pasieczny, N., & Connor, J. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.09.006 · Cited by 116 · see citing works
The Utility of Home-Practice in Mindfulness-Based Group Interventions: A Systematic Review
Lloyd, A., White, R. G., Eames, C., & Crane, R. S. (2017) · Mindfulness · doi:10.1007/s12671-017-0813-z · Cited by 113 · see citing works
Self-citationWagner, T., Fydrich, T., Stiglmayr, C., Marschall, P., Salize, H.-J., Renneberg, B., Fleßa, S., & Roepke, S. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.07.004 · Cited by 92 · see citing works
Kuyken, W., Hayes, R. A., Barrett, B. M., Byng, R., Dalgleish, T., Kessler, D. S., Lewis, G., Watkins, E. R., Morant, N. J., Taylor, R. S., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19730 · Cited by 82 · see citing works
Measuring and valuing mental health for use in economic evaluation
Brazier, J. E. (2008) · Journal of Health Services Research & Policy · doi:10.1258/jhsrp.2008.008015 · Cited by 66 · see citing works
van Ravesteijn, H., Grutters, J., olde Hartman, T., Lucassen, P., Bor, H., van Weel, C., van der Wilt, G. J., & Speckens, A. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.01.001 · Cited by 45 · see citing works
Luciano, J. V., D'Amico, F., Feliu-Soler, A., McCracken, L. M., Aguado, J., Peñarrubia-María, M. T., Knapp, M., Serrano-Blanco, A., & García-Campayo, J. (2017) · The Journal of Pain · doi:10.1016/j.jpain.2017.03.001 · Cited by 42 · see citing works
Fjorback, L. O., Carstensen, T. B. W., Arendt, M. C. B. B., Ørnbøl, E., Walach, H., Rehfeld, E., & Fink, P. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.09.010 · Cited by 35 · see citing works
Finnes, A., Enebrink, P., Sampaio, F., Sorjonen, K., Dahl, J., Ghaderi, A., Nager, A., & Feldman, I. (2017) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0000000000001156 · Cited by 28 · cited 8× · see citing works
“…in which all costs and benefits associated with the interventions in question were taken into account, irrespective of what entity they accrued to (Finnes et al., 2017; Kuyken, et al., 2008; Kuyken, Hayes, Barrett, Byng, Dalgleish, Kessler, Lewis, Watkins, Brejcha, et al., 2015; Kuyken, Hayes,…”
BackgroundResultInfluentialLengacher, C. A., Kip, K. E., Reich, R. R., Craig, B. M., Mogos, M. F., Ramesar, S., Paterson, C. L., Farias, J. R., & Pracht, E. E. (2015) · PubMed · Cited by 28 · see citing works
Early Buddhist Mindfulness and Memory, the Body, and Pain
Anālayo, B. (2016) · Mindfulness · doi:10.1007/s12671-016-0573-1 · Cited by 27 · see citing works
Edwards, R. T., Bryning, L., & Crane, R. S. (2014) · Mindfulness · doi:10.1007/s12671-014-0282-6 · Cited by 22 · see citing works
Mindfulness-based cognitive therapy for recurrent major depression: A ‘ best buy ’ for health care?
Shawyer, F., Enticott, J., Özmen, M., Inder, B., & Meadows, G. N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416642847 · Cited by 22 · see citing works
The Effect of DBT Provision in Reducing the Cost of Adults Displaying the Symptoms of BPD
Amner, K. (2012) · British Journal of Psychotherapy · doi:10.1111/j.1752-0118.2012.01286.x · Cited by 21 · see citing works
Prioli, K. M., Pizzi, L. T., Kash, K. M., Newberg, A. B., Morlino, A. M., Matthews, M. J., & Monti, D. (2017) · PubMed Central · Cited by 18 · see citing works
Cost-Effectiveness of the Mindfulness-Based Stress Reduction Methodology
Knight, R. W., Bean, J., Wilton, A. S., & Lin, E. H. B. (2015) · Mindfulness · doi:10.1007/s12671-015-0408-5 · Cited by 15 · see citing works
Fjorback, L., Arendt, M., Agervig Carstensen, T., Fink, P., Ørnbøl, E., Rehfeld, E., & Walach, H. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.03.004 · Cited by 5 · see citing works
Bota, R. G., Hazen, J., Tieu, R. S., & Novac, A. (2016) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.16m01985 · Cited by 2 · see citing works
P04.69. Investing in integrative medicine for mental health and wellbeing: making the economic case
McDaid, D., & Park, A. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-s1-p339 · Cited by 1 · see citing works
Murphy, A., & Bourke, J. (2014) · Value in Health · doi:10.1016/j.jval.2014.08.1288 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- Fjorback L., 2012, Mindfulness therapy for Bodily distress syndrome: Economic evaluation alongside a randomized trial, Journal of Psychosomatic Research, 72, 480
- Higgins J. P. T., 2011, Cochrane handbook for systematic reviews of interventions version 5.1.0
- Holmes M., 2007, A probabilistic cost‐effectiveness analysis of psychological therapies including dialectical behaviour therapy for borderline personality disorder, Journal of Mental Health Policy and Economics, 10, S18
- NICE, 2009, Depression in adults: Recognition and management. Clinical guideline 90
- Shemilt I., 2011, Cochrane handbook for systematic reviews of interventions version 5.1.0, 449
- Roijen L. H., 2015, Cost‐effectiveness and cost‐utility of Shortterm inpatient dialectical behavior therapy for chronically parasuicidal BPD (Young) adults, Journal of Mental Health Policy and Economics, 18, S19
Cited by
Sorted by citations
Mindfulness-based interventions: an overall review
Zhang, D., Lee, E. K. P., Mak, E. C. W., Ho, C. Y., & Wong, S. Y. S. (2021) · British Medical Bulletin · doi:10.1093/bmb/ldab005 · Cited by 668 · see citing works
Pérez-Aranda, A., Feliu-Soler, A., Montero-Marín, J., García-Campayo, J., Andrés-Rodríguez, L., Borràs, X., Rozadilla-Sacanell, A., Peñarrubia-Maria, M. T., Angarita-Osorio, N., McCracken, L. M., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001655 · Cited by 98 · see citing works
Dewitte, M., Bettocchi, C., Carvalho, J., Corona, G., Flink, I., Limoncin, E., Pascoal, P., Reisman, Y., & Van Lankveld, J. (2021) · Sexual Medicine · doi:10.1016/j.esxm.2021.100434 · Cited by 97 · see citing works
McCartney, M., Nevitt, S., Lloyd, A., Hill, R., White, R., & Duarte, R. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13242 · Cited by 93 · see citing works
Self-citationMindfulness for Global Public Health: Critical Analysis and Agenda
Oman, D. (2025) · Mindfulness · doi:10.1007/s12671-023-02089-5 · Cited by 87 · see citing works
Pérez, V., Menéndez-Crispín, E. J., Sarabia-Cobo, C., de Lorena, P., Fernández-Rodríguez, A., & González-Vaca, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811441 · Cited by 77 · see citing works
Mental Health Apps in Psychiatric Treatment: A Patient Perspective on Real World Technology Usage
Chiauzzi, E., & Newell, A. (2019) · JMIR Mental Health · doi:10.2196/12292 · Cited by 46 · see citing works
Economic Evaluations of Mindfulness-Based Interventions: a Systematic Review
Zhang, L., Lopes, S. S., Lavelle, T. A., Jones, K. O., Chen, L., Jindal, M., Zinzow, H. M., & Shi, L. (2022) · Mindfulness · doi:10.1007/s12671-022-01960-1 · Cited by 45 · see citing works
Compen, F. R., Adang, E., Bisseling, E., van der Lee, M. L., & Speckens, A. E. M. (2019) · Psycho-Oncology · doi:10.1002/pon.5246 · Cited by 38 · see citing works
Barlow, I. U., Lee, E., & Saling, L. (2024) · European Eating Disorders Review · doi:10.1002/erv.3032 · Cited by 31 · see citing works
Pérez‐Aranda, A., D’Amico, F., Feliu‐Soler, A., McCracken, L. M., Peñarrubia‐María, M. T., Andrés‐Rodríguez, L., Angarita‐Osorio, N., Knapp, M. R. J., García‐Campayo, J., & Luciano, J. V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071068 · Cited by 28 · see citing works
Sanabria-Mazo, J. P., Forero, C. G., Cristobal-Narváez, P., Suso-Ribera, C., García-Palacios, A., Colomer-Carbonell, A., Pérez-Aranda, A., Andrés-Rodríguez, L., McCracken, L. M., D'Amico, F., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038107 · Cited by 16 · see citing works
D’Amico, F., Feliu‐Soler, A., Montero‐Marín, J., Peñarrubia‐María, M. T., Navarro‐Gil, M., Gordon, W. V., García‐Campayo, J., & Luciano, J. V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030726 · Cited by 15 · see citing works
Should Individuals Choose Their Own Incentives? Evidence from a Mindfulness Meditation Intervention
Woerner, A., Romagnoli, G., Probst, B. M., Bartmann, N., Cloughesy, J. N., & Lindemans, J. W. (2024) · Management Science · doi:10.1287/mnsc.2021.04157 · Cited by 13 · see citing works
Kuriakose, S., & Armand, Y. M. (2021) · Physician Assistant Clinics · doi:10.1016/j.cpha.2021.02.002 · Cited by 10 · see citing works
Prehabilitation: The underutilised weapon for chronic pain management
Tidmarsh, L. V., Harrison, R. N., & Finlay, K. A. (2024) · British Journal of Pain · doi:10.1177/20494637241250239 · Cited by 10 · see citing works
Kallitsoglou, A., & Topalli, P. (2024) · Frontiers in Sociology · doi:10.3389/fsoc.2024.1168465 · Cited by 8 · see citing works
Shubina, I. (2022) · Interactive Journal of Medical Research · doi:10.2196/41456 · Cited by 7 · see citing works
Wagner, A. P., Galante, J., Dufour, G., Barton, G., Štochl, J., Vainre, M., & Jones, P. B. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-071724 · Cited by 7 · see citing works
Kallitsoglou, A., & Topalli, P. (2021) · Research Square · doi:10.21203/rs.3.rs-333649/v1 · Cited by 7 · see citing works
What is the evidence in evidence-based mindfulness programs for children?
Butterfield, K. M., Roberts, K. P., Feltis, L. E., & Kocovski, N. L. (2020) · Advances in child development and behavior · doi:10.1016/bs.acdb.2020.01.007 · Cited by 6 · see citing works
A Terapia do Esquema (TE) no tratamento dos transtornos de personalidade do Cluster B
Soares, L. B., & Carlesso, J. P. P. (2021) · Research Society and Development · doi:10.33448/rsd-v10i15.22561 · Cited by 4 · see citing works
Mindfulness: Why it may work and why it is sure to succeed
Errasti, J. M., Al‐Halabí, S., López-Navarro, E., & Álvarez, M. P. (2022) · Behavioral Psychology/Psicología Conductual · doi:10.51668/bp.8322112n · Cited by 4 · see citing works
D’Amico, F., Navarrete, J., Montero‐Marín, J., Cardeñosa, E., Navarro‐Gil, M., Pérez‐Aranda, A., del Hoyo, Y. L., Collado‐Navarro, C., García‐Campayo, J., & Luciano, J. V. (2024) · Mindfulness · doi:10.1007/s12671-024-02319-4 · Cited by 4 · see citing works
Mauliza, M., Nurdasila, N., & Chan, S. (2022) · Journal of Economics Finance and Management Studies · doi:10.47191/jefms/v5-i12-04 · Cited by 3 · see citing works
Realizing the Economic Potential of Meditation and Mindfulness Practices in Mental Health Care
Chhatwal, J., & Fleurence, R. (2025) · Value in Health · doi:10.1016/j.jval.2025.04.2164 · Cited by 3 · see citing works
Willim, A. P. (2022) · Quantitative Economics and Management Studies · doi:10.35877/454ri.qems1104 · Cited by 1 · see citing works
Mindfulness and physical health among college students: A latent profile analysis
Jaurequi, M. E., Love, H., Taylor, S., & Barnes, A. (2025) · Journal of American College Health · doi:10.1080/07448481.2025.2459749 · Cited by 1 · see citing works
Meng, H., Lengacher, C. A., Tate, R., Rodriguez, C. S., Kip, K. E., Park, J. Y., Hueluer, G., Nguyen, A. T. H., Morgan, S. P., Tinsley, S., et al. (2025) · Psycho-Oncology · doi:10.1002/pon.70220 · Cited by 1 · see citing works
Mindful-based Interventions for the Development of Leadership Success
Bao, Y. (2023) · Journal of Education Humanities and Social Sciences · doi:10.54097/ehss.v17i.10469 · Cited by 1 · see citing works
La pleine conscience (mindfulness) en neurologie : qu’en attendre ?
Tison, F. (2024) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2024.10.004 · Cited by 1 · see citing works
ghehi, A. T., Moradi, H., & Bigdeli, H. (2023) · journal of Adolescent and Youth Psychological Studies · doi:10.52547/jspnay.4.3.72 · Cited by 1 · see citing works
Osstyn, S., Rauwenhoff, J., Handels, R., de Vugt, M. E., Evers, S., van Mastrigt, G. A. P. G., & van Heugten, C. M. (2025) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462324004811
Mindfulness-Based Interventions during Pregnancy and Labour
Merchante, M. S., & Martinez-Hurtado, E. D. (2022) · Recent advances in anesthesiology · doi:10.2174/9789815051841122040022
ghehi, A. T., Moradi, H., & Bigdeli, H. (2023) · doi:10.61838/kman.jayps.4.3.6
Research Progress on the Application of Mindfulness Training among College Students
Wang, M. (2024) · Advances in Psychology · doi:10.12677/ap.2024.143128
Tasneem, S. A., Thomas, K. A., & Panwar, N. (2024) · Research Square · doi:10.21203/rs.3.rs-4175611/v1
Ruíz-Íñiguez, R., Sacristán-Martín, O., Burgos-Julián, F. A., Casillas-Barragán, B., Resurrección, D., & Duncan, L. G. (2025) · Mindfulness · doi:10.1007/s12671-025-02694-6
- Authors
- Duarte, R., Lloyd, A., Kotas, E., Andronis, L., & White, R.
- Affiliations
- University of Liverpool (GB)
- NHS Greater Glasgow and Clyde (GB)
- University of Warwick (GB)
- Corresponding author
- Duarte, Rui
- Venue
- British Journal of Clinical Psychology
- Publisher
- Wiley
- Published
- 2018-11-29
- Volume
- 58
- Issue
- 2
- Pages
- 187-210
- ISSN
- 0144-6657 (ISSN-L)
- 2044-8260
- PMC
- PMC6588093
- OpenAlex
- W2902777321
- Semantic Scholar
- e42eb08bb3c61d7894db754ad443c9af874bcb70
- Cited by
- 39
- References
- 59
- Citations by year
- 2025: 5 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 6 · 2020: 4 · 2019: 4
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- British Journal of Clinical Psychology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Warwick Research Archive Portal (University of Warwick) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- acceptance and commitment therapy, dialectical behavior therapy, mindfulness-based cognitive therapy, mindfulness-based stress reduction, cost-effectiveness, economic evaluation, mental illness, depression, value for money, cost reduction
- MeSH terms
- Cost-Benefit Analysis, Female, Humans, Male, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review